1H MR spectroscopic imaging of the prostate at 7T using spectral‐spatial pulses

To assess the feasibility of prostate 1H MR spectroscopic imaging (MRSI) using low‐power spectral‐spatial (SPSP) pulses at 7T, exploiting accurate spectral selection and spatial selectivity simultaneously.

[1]  Peder E. Z. Larson,et al.  Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. , 2008, Journal of magnetic resonance.

[2]  P. Luijten,et al.  Composite slice‐selective adiabatic excitation for prostate MRSI , 2013, NMR in biomedicine.

[3]  E. Rothgang,et al.  In vivo 31P MR spectroscopic imaging of the human prostate at 7 T: Safety and feasibility , 2012, Magnetic resonance in medicine.

[4]  A. Heerschap,et al.  Proton spectroscopic imaging of the human prostate at 7 T , 2009, NMR in biomedicine.

[5]  M. van der Graaf,et al.  In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. , 1997, Anticancer research.

[6]  J. Kurhanewicz,et al.  Multiparametric 3T endorectal mri after external beam radiation therapy for prostate cancer , 2012, Journal of magnetic resonance imaging : JMRI.

[7]  Arend Heerschap,et al.  Metabolite ratios in 1H MR spectroscopic imaging of the prostate , 2015, Magnetic resonance in medicine.

[8]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[9]  Dennis W J Klomp,et al.  Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.

[10]  A. Sherry,et al.  Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla* , 2008, Journal of Lipid Research.

[11]  T. Scheenen,et al.  Detection of fully refocused polyamine spins in prostate cancer at 7 T , 2011, NMR in biomedicine.

[12]  J. Pauly,et al.  Improved solvent suppression and increased spatial excitation bandwidths for three‐dimensional press CSI using phase‐compensating spectral/spatial spin‐echo pulses , 1997, Journal of magnetic resonance imaging : JMRI.

[13]  D. Klomp,et al.  In vivo GABA T2 determination with J‐refocused echo time extension at 7 T , 2013, NMR in biomedicine.

[14]  A. Macovski,et al.  Variable-rate selective excitation , 1988 .

[15]  Rolf Gruetter,et al.  Proton T1 relaxation times of metabolites in human occipital white and gray matter at 7 T , 2013, Magnetic resonance in medicine.

[16]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[17]  Michael Lustig,et al.  Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. , 2008, Journal of magnetic resonance.

[18]  Oliver Kraff,et al.  Feasibility of T2‐weighted turbo spin echo imaging of the human prostate at 7 tesla , 2014, Magnetic resonance in medicine.

[19]  T. Scheenen,et al.  Mapping of prostate cancer by 1H MRSI , 2014, NMR in biomedicine.

[20]  M. van der Graaf,et al.  Echo-time independent signal modulations using PRESS sequences: a new approach to spectral editing of strongly coupled AB spin systems. , 2005, Journal of magnetic resonance.

[21]  H. Hricak,et al.  Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. , 2007, Radiology.

[22]  P. Carroll,et al.  Quantification of choline‐ and ethanolamine‐containing metabolites in human prostate tissues using 1H HR‐MAS total correlation spectroscopy , 2008, Magnetic resonance in medicine.

[23]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[24]  K. Uğurbil,et al.  Analysis of wave behavior in lossy dielectric samples at high field , 2002, Magnetic resonance in medicine.

[25]  P. Carroll,et al.  Quantitative analysis of prostate metabolites using 1H HR‐MAS spectroscopy , 2006, Magnetic resonance in medicine.

[26]  Arend Heerschap,et al.  Proton MR spectroscopy of prostatic tissue focused on the etection of spermine, a possible biomarker of malignant behavior in prostate cancer , 2000, Magnetic Resonance Materials in Physics, Biology and Medicine.

[27]  N. deSouza,et al.  Evaluation of short-TE 1H MRSI for quantification of metabolites in the prostate , 2014, NMR in biomedicine.

[28]  T. Bolz,et al.  An 8-channel add-on RF shimming system for whole-body 7 Tesla MRI including real-time SAR monitoring , 2008 .

[29]  Jian-ming Li,et al.  Comparative Analysis between SPECT Myocardial Perfusion Imaging and CT Coronary Angiography for Diagnosis of Coronary Artery Disease , 2012, International journal of molecular imaging.

[30]  T. Scheenen,et al.  Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. , 2012, Radiology.

[31]  John M Pauly,et al.  High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. , 2006, Magnetic resonance imaging.

[32]  T. Scheenen,et al.  Phosphorus Magnetic Resonance Spectroscopic Imaging at 7 T in Patients With Prostate Cancer , 2014, Investigative radiology.

[33]  A. Allouche,et al.  DFT calculations of isomer effects upon NMR spin-Hamiltonian parameters of prostate polyamines , 2010 .

[34]  Michael Garwood,et al.  Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T , 2005, Magnetic resonance in medicine.

[35]  Jason A Koutcher,et al.  Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience. , 2005, Radiology.

[36]  J. Witjes,et al.  High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[37]  Arend Heerschap,et al.  Fast acquisition‐weighted three‐dimensional proton MR spectroscopic imaging of the human prostate , 2004, Magnetic resonance in medicine.

[38]  G B Matson,et al.  Comparison of k‐space sampling schemes for multidimensional MR spectroscopic imaging , 1996, Magnetic resonance in medicine.

[39]  T. Bathen,et al.  Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness , 2013, PloS one.

[40]  K..  How we do it. , 1966, The Journal of school health.

[41]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[42]  A Macovski,et al.  Echo‐planar spin‐echo and inversion pulses , 1993, Magnetic resonance in medicine.

[43]  N. deSouza,et al.  The effect of experimental conditions on the detection of spermine in cell extracts and tissues , 2009, NMR in biomedicine.

[44]  Yan Li,et al.  T1 and T2 Metabolite Relaxation Times in Normal Brain at 3T and 7T , 2013 .

[45]  P R Luijten,et al.  Improving SNR and B1 transmit field for an endorectal coil in 7 T MRI and MRS of prostate cancer , 2012, Magnetic resonance in medicine.

[46]  J. Pauly,et al.  Dualband spectral‐spatial RF pulses for prostate MR spectroscopic imaging , 2001, Magnetic resonance in medicine.

[47]  G. Metzger,et al.  Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject‐dependent transmit phase measurements , 2008, Magnetic resonance in medicine.

[48]  T. Scheenen,et al.  31P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization , 2015, Magnetic resonance in medicine.

[49]  Michael Garwood,et al.  Solvent Suppression Using Selective Echo Dephasing , 1996 .

[50]  Steen Moeller,et al.  Performance of external and internal coil configurations for prostate investigations at 7 T , 2010, Magnetic resonance in medicine.

[51]  T. Scheenen,et al.  Prostate MRI and 3D MR spectroscopy: how we do it. , 2010, AJR. American journal of roentgenology.